Correlation Between Mangalam Drugs and Reliance Communications

Can any of the company-specific risk be diversified away by investing in both Mangalam Drugs and Reliance Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangalam Drugs and Reliance Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mangalam Drugs And and Reliance Communications Limited, you can compare the effects of market volatilities on Mangalam Drugs and Reliance Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangalam Drugs with a short position of Reliance Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangalam Drugs and Reliance Communications.

Diversification Opportunities for Mangalam Drugs and Reliance Communications

0.72

Correlation Coefficient

Mangalam Drugs  Reliance Communications

Poor diversification

The 3 months correlation between Mangalam and Reliance is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Mangalam Drugs And and Reliance Communications Limite in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reliance Communications and Mangalam Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangalam Drugs And are associated (or correlated) with Reliance Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reliance Communications has no effect on the direction of Mangalam Drugs i.e., Mangalam Drugs and Reliance Communications go up and down completely randomly.

Pair Corralation between Mangalam Drugs and Reliance Communications

Assuming the 90 days trading horizon Mangalam Drugs And is expected to generate 1.32 times more return on investment than Reliance Communications. However, Mangalam Drugs is 1.32 times more volatile than Reliance Communications Limited. It trades about -0.14 of its potential returns per unit of risk. Reliance Communications Limited is currently generating about -0.22 per unit of risk. If you would invest  11,363  in Mangalam Drugs And on December 26, 2024 and sell it today you would lose (3,393) from holding Mangalam Drugs And or give up 29.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Mangalam Drugs And  vs.  Reliance Communications Limite

Mangalam Drugs And

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mangalam Drugs And has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Reliance Communications

Risk-Adjusted Performance

Very Weak

Over the last 90 days Reliance Communications Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Mangalam Drugs and Reliance Communications

The main advantage of trading using opposite Mangalam Drugs and Reliance Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangalam Drugs position performs unexpectedly, Reliance Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reliance Communications will offset losses from the drop in Reliance Communications' long position.

The idea behind Mangalam Drugs And and Reliance Communications Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.